Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Dr.-Adil-Agarwal"

3 News Found

Dr Agarwal's Eye Hospital merges with parent Dr Agarwal's Health Care
News | August 29, 2025

Dr Agarwal's Eye Hospital merges with parent Dr Agarwal's Health Care

Merger is expected to streamline operations and provide unified management focus, driving efficiency and strategic alignment

Dr. Agarwal's Health Care raises US$80 mn from TPG and Temasek to expand network to 300 hospitals
Healthcare | August 20, 2023

Dr. Agarwal's Health Care raises US$80 mn from TPG and Temasek to expand network to 300 hospitals

The company has new projects in development in Mumbai, Punjab, central and northern India, among others

Dr. Agarwal's Health Care raises over Rs 1,000 crore from TPG Growth and Temasek
Hospitals | May 11, 2022

Dr. Agarwal's Health Care raises over Rs 1,000 crore from TPG Growth and Temasek

The company also raised Rs 270 crore investment from Temasek in 2019

Latest Stories

Novartis India posts Q2 FY26 PAT at Rs. 24.22 Cr

Granules India’s facility secures FDA EIR with 'VAI’

Lilly to invest $1.2 billion+ to boost oral medicine manufacturing capacity in US

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
India remains a very important part of our ecosystem: Vaios Barlas, Global Director Healthcare, Clariant and Bhushan Thekedar, Head of Global Business Development Healthcare, Clariant
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India
Dr. R. Ananthanarayanan CEO, Sajjan India
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Our focus is on organic expansion and building our own plants...: Dr. Aman Desai, Promoter and Whole Time Director, Aether Industries
Dr. Aman Desai Promoter and Whole Time Director, Aether Industries

Packaging